|4Aug 4, 5:46 PM ET

FROM STEPHEN 4

4 · EYEGATE PHARMACEUTICALS INC · Filed Aug 4, 2021

Insider Transaction Report

Form 4
Period: 2021-08-03
FROM STEPHEN
DirectorPresident and CEO
Transactions
  • Tax Payment

    Common Stock

    2021-08-03$2.40/sh261$62669,044 total
Footnotes (1)
  • [F1]Sale of shares to cover taxes due on restricted stock that vested on 08/01/2021.

Documents

1 file
  • 4
    tm2124160d4_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT